Blepharophimosis-intellectual disability syndrome, Verloes type is a rare genetic condition that affects eye shape and development and learning. Features usually begin in infancy and are lifelong. Children with this condition often have narrow eye openings, droopy eyelids, and developmental delay, and doctors may also see differences in facial shape and growth. Treatment focuses on supportive care like early therapies for learning and behavior and eye and eyelid surgery when needed. The outlook varies, but many people with Blepharophimosis-intellectual disability syndrome, Verloes type can improve comfort and function with coordinated care.
Overview
Blepharophimosis-intellectual disability syndrome, verloes typeSymptoms
Blepharophimosis-intellectual disability syndrome, Verloes type is recognized at birth by narrow eye openings and droopy eyelids that can affect vision. Many also have developmental delay, learning challenges, and speech and motor delays.
Outlook and prognosis
Most children with Blepharophimosis–intellectual disability syndrome, Verloes type grow and learn at their own pace, often needing lifelong supports. Early therapies for movement, communication, and vision can improve daily skills and comfort. Regular follow-up with genetics, neurology, and eye specialists helps prevent complications and guides care over time.
Causes and risk factors
Blepharophimosis-intellectual disability syndrome, Verloes type is a congenital genetic condition, usually due to a change in a single gene. Most cases appear sporadically; a family history or parental relatedness can raise risk. Environmental or lifestyle factors are not known causes.
Genetic influences
Genetics play a central role in Blepharophimosis-intellectual disability syndrome, Verloes type. It’s typically caused by inherited or new (de novo) changes in a single gene, affecting early brain and facial development. Genetic testing confirms the diagnosis and guides family planning.
Diagnosis
Doctors suspect it from characteristic eyelid narrowing, facial shape, developmental delays, and sometimes brain imaging findings. Targeted genetic testing confirms the diagnosis; early genetic diagnosis of Blepharophimosis-intellectual disability syndrome, Verloes type helps plan care and family counseling.
Treatment and drugs
Treatment for Blepharophimosis–intellectual disability syndrome, Verloes type focuses on supportive, tailored care. Teams may combine early therapies for development and communication, eye and eyelid surgeries to improve vision, and management of feeding, sleep, or movement challenges as they arise. Regular follow‑up helps adjust plans over time.
Symptoms
Small eye openings and droopy lids can make it harder to see clearly, especially when looking up or in dim light. Blepharophimosis-intellectual disability syndrome, Verloes type is a genetic condition present from birth that mainly affects the eyelids and development. Features vary from person to person and can change over time. Early features of Blepharophimosis-intellectual disability syndrome, Verloes type often include the eyelid changes along with delays in sitting, speaking, or learning.
The openings of the eyes are shorter than usual and the upper lids can droop (ptosis). Clinicians call this blepharophimosis, which means the lids limit the line of sight. Children may tip the chin up or lift the eyebrows to see better.
The droopy lids can block part of the pupil, leading to eye strain, headaches, or fatigue with reading. Regular eye checks help protect vision as the eyes and brain develop.
In Blepharophimosis-intellectual disability syndrome, Verloes type, sitting, crawling, and walking can happen later than expected. Early physical and occupational therapy support motor skills and independence.
Learning and problem-solving are affected to varying degrees. Many people with Blepharophimosis-intellectual disability syndrome, Verloes type benefit from individualized education plans and extra time to learn new skills.
How people usually first notice Blepharophimosis-intellectual disability syndrome, verloes type?
Many families first notice something different in the newborn period: babies often have very narrow eye openings with droopy eyelids (blepharophimosis and ptosis), widely spaced eyes, and a small lower jaw, which prompts an early eye or genetics referral. As infants grow, doctors may note feeding difficulties, low muscle tone, slow head growth, and later, developmental delays and intellectual disability, which together raise concern for a syndromic cause. In practice, the first signs of Blepharophimosis-intellectual disability syndrome, Verloes type are the distinctive eyelid features at birth, with developmental differences becoming clearer over the first months to years.
Types of Blepharophimosis-intellectual disability syndrome, verloes type
Blepharophimosis–intellectual disability syndrome, Verloes type is a rare genetic condition with a consistent core pattern, but clinicians recognize a few clinical variants based on how early features appear and how broad the body-wide involvement is. People with this condition often share eyelid differences, developmental delays, and learning differences, yet the range of movement, feeding, and growth concerns can vary. Not everyone will experience every type. Here are the main types to know about:
Classic Verloes type
This variant includes the hallmark eyelid narrowing with significant developmental delay and learning disability. Many also have low muscle tone, feeding challenges in infancy, and later speech delay.
Severe early-onset
Symptoms show up very early with marked feeding problems, poor growth, and more pronounced movement or coordination issues. Early symptoms of blepharophimosis–intellectual disability syndrome can include weak muscle tone and delayed milestones.
Milder spectrum
Core facial and eyelid features are present, but motor and learning challenges are less pronounced. Children may walk and talk closer to typical timelines, with school supports helping day-to-day learning.
Associated malformations
In addition to the classic features, some have extra organ involvement such as heart, kidney, or limb differences. This variant can bring added medical visits and monitoring alongside developmental care.
What genetics can tell you about symptoms
Some people with BPIDS, Verloes type develop small, narrow eyelid openings, droopy lids, and wide-set eyes because variants in the KAT6B gene disrupt proteins that guide early face and eyelid development. The same variants can also alter brain development, linking them to intellectual disability and delayed speech.
Causes and risk factors
The main cause is a change in a gene that affects early development.
In Blepharophimosis-intellectual disability syndrome, Verloes type, this change most often happens for the first time and is not caused by parents’ actions.
Rarely, it can run in a family, so a parent with the same change can pass it to a child.
No diet, toxin, or activity is known to cause this syndrome, but overall pregnancy health can influence how strongly some features show.
Doctors distinguish between risk factors you can change and those you can’t, and a genetics visit can explain your personal chance and the risk factors for Blepharophimosis-intellectual disability syndrome, Verloes type.
Environmental and biological risk factors
Blepharophimosis-intellectual disability syndrome, Verloes type is a rare condition that begins during early development before birth. At this time, environmental risk factors for Blepharophimosis-intellectual disability syndrome, Verloes type have not been identified with confidence, and most cases appear to occur unexpectedly. In general, biology seems to play the larger role, while harmful exposures are not clearly linked. Researchers are still exploring how outside influences interact with our inner biology.
Older paternal age can raise the chance of age‑related changes during sperm formation. This may slightly increase the likelihood of rare, sporadic conditions like Blepharophimosis-intellectual disability syndrome, Verloes type.
Early weeks of pregnancy are when facial and brain structures form. Severe exposures during this window can disrupt development in general, but they have not been shown to cause this specific syndrome.
No particular chemical, medication, or environmental exposure has been confirmed to cause Blepharophimosis-intellectual disability syndrome, Verloes type. Usual levels of air pollution or household products have not been linked to this condition.
Serious, uncontrolled illnesses or very high fever can affect fetal development broadly. There is no clear evidence that common maternal health issues raise the risk for this syndrome.
Genetic risk factors
Blepharophimosis-intellectual disability syndrome, Verloes type is linked to changes in a single gene involved in early development of the face and brain. In many families there is no prior history because the change arises for the first time in the child. Genetic changes usually drive the condition long before any early symptoms of Blepharophimosis-intellectual disability syndrome, Verloes type appear. Some risk factors are inherited through our genes.
Single-gene change: A change in one gene disrupts typical eyelid and brain development. This is the core genetic cause of Blepharophimosis-intellectual disability syndrome, Verloes type.
Often de novo: In many people, the genetic change is new and not present in either parent. This explains why there may be no family history.
Inheritance possible: If a parent carries the same change, it can be passed to children. The chance of passing it on depends on the specific gene and finding; a genetics team can clarify the exact risk.
Variable expression: The same genetic change can lead to different levels of learning difficulties, eyelid shape, or other features. This variability makes it hard to predict how strongly a child will be affected.
Parental mosaicism: Rarely, a parent may have the change in a small portion of their egg or sperm cells but not in blood tests. This can slightly increase the chance of having another child with the condition.
Family history clues: Multiple relatives with similar eyelid features or developmental differences can point to an inherited change. Sharing this pattern helps guide testing and risk estimates.
Genetic testing: A molecular test can look for the single-gene change and confirm the cause. Knowing the exact change informs recurrence risks and options for future pregnancies.
Lifestyle risk factors
Blepharophimosis-intellectual disability syndrome, Verloes type is a genetic condition; lifestyle habits do not cause it. However, daily routines can influence comfort, function, and the risk of complications. The points below focus on how lifestyle affects Blepharophimosis-intellectual disability syndrome, verloes type by shaping vision comfort, motor abilities, communication, sleep, and overall health. Diet and physical activity play roles when feeding safety, nutrition, and mobility are involved.
Bright, even lighting and regular visual breaks can reduce eye fatigue from blepharophimosis and ptosis. Excessive glare or prolonged near work may increase headaches, squinting, and visual discomfort.
Consistent use of prescribed glasses, lubricating drops, or eyelid hygiene can protect the cornea in eyes prone to exposure or dryness. Skipping these measures raises the risk of irritation, tearing, and infections that can worsen visual function.
Daily low-impact activity and therapist-guided exercises can improve tone, balance, and joint mobility in hypotonia. Sedentary routines increase stiffness, contractures, and fall risk, limiting independence.
Texture-modified foods, upright posture, slow pacing, and adequate hydration can reduce choking and aspiration in oromotor dysfunction. Rushed meals or hard-to-chew foods raise pneumonia risk and can lead to poor growth.
Risk prevention
Blepharophimosis-intellectual disability syndrome, Verloes type is present from birth, so you can’t prevent it outright. Prevention works best when combined with regular check-ups. What you can do is lower the chance of complications, support development, and protect vision, hearing, breathing, and nutrition. A coordinated care plan started early often makes day-to-day life easier.
Early and frequent eye exams help protect vision and catch irritation or dry eyes from reduced blinking. Treatment plans often include lubricating drops and shielding from bright light.
If eyelid opening is very limited, planned surgery can widen the field of vision. Better vision early on can support learning and movement in children with Blepharophimosis-intellectual disability syndrome, Verloes type.
Regular hearing checks can spot fluid build-up or hearing loss that might affect speech and learning. Early treatment protects communication skills.
Facial structure can raise the chance of snoring or sleep apnea, so ask about screening if sleep seems restless. Treating sleep-breathing problems helps daytime focus and growth in Blepharophimosis-intellectual disability syndrome, Verloes type.
Transmission
Blepharophimosis-intellectual disability syndrome, Verloes type is a genetic condition and isn’t contagious—you can’t catch it from someone else. Most reported families show an autosomal recessive pattern: both parents carry one silent, changed gene, and when two carriers have a child, there’s a 25% (1 in 4) chance the child will have the condition, a 50% (1 in 2) chance the child will be a healthy carrier, and a 25% chance of inheriting neither change. Sometimes a new (de novo) genetic change can cause the condition in a child with no prior family history. Because genetic transmission of Blepharophimosis-intellectual disability syndrome, Verloes type can vary in rare families, a genetics professional can clarify how Blepharophimosis-intellectual disability syndrome, Verloes type is inherited in your situation and discuss recurrence risks.
When to test your genes
Consider testing if there’s a family history of Blepharophimosis–intellectual disability syndrome, Verloes type, or if a child shows early features like eyelid narrowing, developmental delays, or distinctive facial traits. Genetic confirmation can guide care plans, therapies, and surveillance. Testing is also reasonable before pregnancy or for prenatal planning.
Diagnosis
Blepharophimosis-intellectual disability syndrome, Verloes type is usually recognized in infancy or early childhood by a pattern of facial features and developmental differences. Getting a diagnosis is often a turning point toward answers and support. Doctors confirm what they see with targeted tests so care can be tailored early. In many cases, the genetic diagnosis of Blepharophimosis-intellectual disability syndrome, Verloes type helps guide follow-up and family planning.
Providers look for a consistent pattern, such as very narrow eye openings, droopy eyelids, and distinctive facial shape. Combined with global developmental delays or low muscle tone, this pattern raises suspicion for this syndrome.
An eye specialist measures eyelid opening and checks how well the eyes move and focus. These findings support the clinical impression and help plan any eyelid procedures to improve vision.
Standardized checks of speech, movement, and learning help document early symptoms of developmental delay. Results guide early therapies and track progress over time.
A blood or saliva test can look for changes in genes known to cause this syndrome. Panels or exome testing are often used when features overlap with similar conditions.
Stages of Blepharophimosis-intellectual disability syndrome, verloes type
Blepharophimosis-intellectual disability syndrome, verloes type does not have defined progression stages. It’s present from birth and tends to remain relatively stable over time, though support needs may change as a child grows. Doctors usually start with a conversation about your child’s development and family background, a head‑to‑toe exam, and early symptoms of Blepharophimosis-intellectual disability syndrome, verloes type. Genetic testing is often used to confirm the diagnosis and guide monitoring over time.
Outlook and prognosis
Looking at the long-term picture can be helpful. Many living with Blepharophimosis–intellectual disability syndrome, Verloes type (BIDSVT) grow and learn at their own pace, with extra support for communication, mobility, and daily skills. Some children start walking and talking later than peers and may need ongoing therapies; seizures and feeding issues can also appear, especially in early childhood, and are usually managed with standard treatments. The outlook is not the same for everyone, but most people with BIDSVT will need lifelong support for learning and independence.
Doctors call this the prognosis—a medical word for likely outcomes. Current reports suggest life expectancy may be near typical when serious complications are identified early and managed well, but published data are limited because the condition is rare. The biggest health risks tend to come from uncontrolled epilepsy, breathing or feeding difficulties in infancy, and complications related to low muscle tone or reflux; with coordinated care, these risks can be reduced. Families often want to know how life will change as a child grows, and for many, this can mean steady progress in motor and social skills over the school years, even if academic learning remains significantly affected.
Early care can make a real difference, so keep regular appointments with neurology, genetics, ophthalmology, and rehabilitation teams to adjust therapies as needs change. If you’re wondering about early symptoms of Blepharophimosis–intellectual disability syndrome, Verloes type that might shape long-term outlook, watch for seizure patterns, feeding and growth concerns, sleep-related breathing issues, and significant developmental delays, and bring them to your clinician’s attention promptly. Genetic testing can sometimes provide more insight into prognosis, and not everyone with the same gene change will have the same outlook. Talk with your doctor about what your personal outlook might look like.
Long-term effects
People living with Blepharophimosis-intellectual disability syndrome, verloes type often experience lifelong eye differences and learning needs that shape school, work, and everyday interactions. Long-term effects vary widely, and strengths can sit alongside challenges. Early symptoms of Blepharophimosis-intellectual disability syndrome, verloes type usually appear in infancy—such as narrow eyelid openings and slower developmental milestones—but the long-term picture depends on the individual. Over the years, features commonly involve vision, communication, coordination, and day-to-day independence.
Narrow eyelid openings and droopy lids can limit the visual field and contribute to lazy eye. Some develop crossing of the eyes or depth‑perception difficulties over time. Light sensitivity and eye strain can persist into adulthood.
Intellectual disability is a core feature and can range from mild to more pronounced. Learning often progresses, but at a slower pace than peers. Reading comprehension and abstract reasoning may remain challenging.
First words and sentence building are often delayed. Speech clarity, vocabulary growth, and understanding complex instructions can remain affected. Social communication may also be different from peers.
Low muscle tone and coordination differences can delay crawling, walking, and fine‑motor skills. Handwriting, buttons, and other precise tasks may stay harder. Balance and endurance can be reduced.
How is it to live with Blepharophimosis-intellectual disability syndrome, verloes type?
Living with Blepharophimosis–intellectual disability syndrome, Verloes type often means navigating vision challenges from narrow eye openings and eyelid differences, along with developmental and learning needs that benefit from consistent therapies and structured support. Daily life may involve frequent medical appointments, early-intervention services, special education planning, and practical adaptations at home and school to support communication, mobility, and independence. Families and caregivers often become skilled coordinators—balancing appointments, advocating in educational settings, and creating routines that reduce fatigue and frustration—while also celebrating steady, meaningful progress. Many find that a supportive care team, respite options, and connection with other families ease stress and help everyone thrive.
Treatment and drugs
Treatment for Blepharophimosis–intellectual disability syndrome, Verloes type focuses on easing day-to-day challenges and supporting development over time. Supportive care can make a real difference in how you feel day to day. Eye findings are often managed with eyelid surgery to improve vision and eye comfort, plus regular eye checks; hearing tests and hearing aids may be needed if hearing is reduced. Developmental and behavioral support typically includes early intervention, speech and language therapy, occupational and physical therapy, and tailored educational plans, while seizures—if present—are treated with anti-seizure medicines and regular follow-up. Doctors sometimes recommend a combination of lifestyle changes and drugs, and your care team may also include genetics, neurology, ENT/audiology, ophthalmology, and nutrition to address feeding, growth, sleep, and other associated features.
Non-drug treatment
Blepharophimosis-intellectual disability syndrome, Verloes type affects vision, development, speech, and daily skills, so care focuses on function and comfort at home and school. Non-drug treatments often lay the foundation for progress, with supports that change as needs evolve. Early symptoms of Blepharophimosis-intellectual disability syndrome, Verloes type often prompt referrals to eye doctors, therapists, and educators, which helps build a coordinated plan. Over time, combining therapies tends to help most with communication, mobility, and independence.
Coordinated services in infancy help build motor, feeding, and communication skills. Therapists coach families on daily routines to support learning. Plans are adjusted as milestones are reached.
Sessions focus on understanding words, making sounds, and using gestures or picture boards. Many benefit from augmentative and alternative communication to express needs clearly.
Activities strengthen hand skills, self-care, and sensory processing for calmer, more organized days. Therapists adapt utensils, pencils, and clothing fasteners to increase independence.
Targeted exercises build core strength, balance, and coordination. Gait training and play-based movement help reduce falls and improve stamina.
Your genes may have an impact on how drugs work for you
Medicines for people with Blepharophimosis–intellectual disability syndrome, Verloes type can act differently because gene changes may alter how the body processes drugs or how brain and eye tissues respond. Pharmacogenetic testing and careful dose adjustments can improve benefit and reduce side effects.
Pharmacological treatments
There isn’t a single drug that treats the genetic cause of Blepharophimosis-intellectual disability syndrome, Verloes type; medicines focus on easing day-to-day symptoms and preventing complications. Early symptoms of Blepharophimosis-intellectual disability syndrome, Verloes type—such as reflux, sleep problems, or seizures—may be managed with targeted drugs. Plans often layer medication with therapies, feeding support, and eye or ENT procedures when needed. Not everyone responds to the same medication in the same way.
Levetiracetam, valproate, or lamotrigine can help prevent seizures if they occur. Your doctor will tailor the choice based on seizure type, side effects, and other health needs.
Methylphenidate or amphetamine-based stimulants may improve focus and impulsivity. Nonstimulants like guanfacine or atomoxetine are options if stimulants aren’t suitable.
SSRIs such as sertraline can help with anxiety or repetitive behaviors. For severe irritability or aggression, risperidone or aripiprazole may be considered with close monitoring.
Melatonin can improve sleep onset and regularity. Low-dose clonidine or trazodone may be used when melatonin alone isn’t enough.
Genetic influences
Genetic factors play a central role, with changes in certain genes that steer early development of the eyelids, facial features, and the nervous system. In the Verloes type, patterns seen in multiple siblings born to unaffected parents suggest a recessive inheritance, where each parent silently carries one copy of the change and each child has about a 1 in 4 (25%) chance of being affected (often called autosomal recessive). The exact gene has not been identified in every family, so standard genetic panels may not always find a clear answer.
Family history is one of the strongest clues to a genetic influence. Some families have no obvious history because carriers usually have no symptoms, so a clinical diagnosis is often based on the pattern of features. When early symptoms of Blepharophimosis-intellectual disability syndrome, Verloes type are present, a genetics team can review your family history, explain testing options, and discuss what results may or may not show.
Is Blepharophimosis-intellectual disability syndrome, verloes type genetic?
Genetics play a central role in Blepharophimosis-intellectual disability syndrome, Verloes type. It’s typically caused by inherited or new (de novo) changes in a single gene, affecting early brain and facial development. Genetic testing confirms the diagnosis and guides family planning.
Pharmacogenetics—how genetics influence drug effects
Care focuses on day-to-day needs, so people may use medicines for behavior, sleep, seizures, or pain, and may also need procedures that require anesthesia. Alongside medical history and current medicines, genetic testing can sometimes identify how your body handles certain drugs and help fine-tune the dose. In practical terms, differences in common enzyme genes can make a standard dose of an antidepressant, stimulant, or anti-seizure medicine too strong, too weak, or more likely to cause side effects. There isn’t a condition-specific drug–gene rule yet for Blepharophimosis-intellectual disability syndrome, Verloes type, so clinicians use general pharmacogenetic guidance that applies to the wider population. If anesthesia is planned for eye or airway procedures, the team will tailor medications to airway and muscle-tone features and will ask about any family history of serious reactions to anesthesia. Pharmacogenetic results rarely change the overall treatment of Blepharophimosis-intellectual disability syndrome, Verloes type, but they can help personalize medication choices so they’re safer and more effective for you.
Interactions with other conditions
Living with Blepharophimosis-intellectual disability syndrome, Verloes type often means managing vision needs alongside developmental and learning supports. When common eye issues like farsightedness or a wandering eye are also present, fine‑detail tasks and reading can become even harder, and the risk of “lazy eye” can rise if these aren’t treated early. Doctors call it a “comorbidity” when two conditions occur together. Early symptoms of Blepharophimosis-intellectual disability syndrome, Verloes type can resemble other neurodevelopmental conditions, so overlapping features with autism or attention differences may blur the picture at first and affect how services are arranged.
Some people with Blepharophimosis-intellectual disability syndrome, Verloes type also experience sleep or feeding difficulties, and if these occur together, daytime fatigue and learning progress may be more affected. A condition may “exacerbate” (make worse) symptoms of another—for example, dry eye or frequent infections can worsen vision development, while behavioral challenges can make eye patching or glasses wear harder to stick with. Interactions can look very different from person to person, so plans that coordinate eye care, developmental therapies, and any behavioral supports tend to work best.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described families in which several relatives had narrowed eyelid openings from birth along with learning and developmental challenges. Elders might recall a grandparent who needed help in school and a child who later needed eye surgery, all within the same family line. These early observations hinted that Blepharophimosis–intellectual disability syndrome, Verloes type, tended to run in families.
First described in the medical literature as a pattern combining small horizontal eyelid openings (blepharophimosis), distinctive facial features, and intellectual disability, the condition was initially grouped with other eyelid disorders because the eye findings were the most visible. Over time, descriptions became more detailed, noting speech delay, coordination differences, and, in some, hearing or feeding issues. As medical science evolved, clinicians recognized that this was a broader syndrome, not just an eye condition.
In recent decades, knowledge has built on a long tradition of observation. Careful family studies showed that the condition could appear in multiple generations, suggesting a dominant inheritance pattern in many families. Advances in genetics then identified changes in a single gene as the underlying cause for most people with the Verloes type, helping distinguish it from other look‑alike conditions that share eyelid features but have different causes or courses.
With each decade, the clinical picture has been refined. Earlier reports emphasized facial measurements and eye structure, while later work added developmental trajectories, behavioral profiles, and common medical needs, such as strabismus treatment or support for learning. This shift reflected a broader change in medicine: moving from a snapshot of physical traits to a fuller view of day‑to‑day function and quality of life.
Initially understood only through symptoms, later the diagnosis incorporated genetic testing, which made it easier to confirm the Verloes type, guide counseling on chance of recurrence in a family, and connect families to condition‑specific resources. Despite evolving definitions, the core features—a characteristic eyelid shape present from birth together with developmental differences—have remained the anchor points that clinicians use to recognize the syndrome.
Today’s approach builds on both careful bedside observation and laboratory insight. Historical case series provide long‑term perspectives on growth, learning, and surgical outcomes, while modern registries broaden understanding across different populations. This combined history has led to earlier recognition, more tailored supports in childhood, and clearer guidance for families planning for school, therapies, and eye care.